Larger Infiltration/Aspiration Volumes, Plasma/ Subcutaneous Fluid Lidocaine Levels and Quantitative Abdominal Tissue Accommodation After Water-Assisted Liposuction (WAL): Comparative Safety and Efficacy to Traditional Liposuction (TL) by Sasakiand, Gordon H. & Tevez, Ana
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
6 
Larger Infiltration/Aspiration Volumes, Plasma/ 
Subcutaneous Fluid Lidocaine Levels and 
Quantitative Abdominal Tissue Accommodation 
After Water-Assisted Liposuction (WAL): 
Comparative Safety and Efficacy 
to Traditional Liposuction (TL) 
 Gordon H. Sasaki and Ana Tevez 
Loma Linda University Medical Center Private Practice 
Pasadena, CA RN Pasadena, CA 
USA 
1. Introduction 
Traditional liposuction1 remains a standard procedure for removal of unwanted fat. In 
contrast, water-assisted liposuction34-39(WAL), introduced in the United States less than 
three years ago, utilizes larger volumes of superwet tumescent anesthesia in small-moderate 
volume liposuction than that commonly employed by traditional liposuction (TL) in 
comparable cases. In larger infiltration-volume WAL cases, therefore, potential fluid 
overloading and lidocaine side-effects can occur as a consequence of technique. Thus, the 
first purpose of this preliminary report is to compare the infiltration and aspiration volumes, 
operating and recovery times, urine output rates in surgery and in the recovery period in 
larger infiltration-volume WAL cases to similar volume cases treated by traditional 
liposuction. The second purpose is to determine lidocaine levels in plasma and fluids within 
the subcutaneous space over 24 hours in a separate cohort of two patients undergoing 
larger-volume WAL procedures. The third purpose is to determine quantitatively by 3D 
Vector Analysis the significance of the WAL technique on percentages of tissue area 
reduction within panels on the lower abdomen in three separate patients.  
2. Patient and methods 
2.1 Study designs 
All consented participants underwent either WAL or traditional liposuction procedures 
under local anesthesia by superwet tumescent infiltration and were offered preoperative 
oral sedation. An intravenous catheter was inserted in the arm as an access for drugs and 
intravenous fluid support during the entire surgical procedure and recovery period. The 
following demographic measurements were obtained prior to surgery: age, weight (kg), 
height (m), BMI, body fat analysis (Futrex 5500, Futrex Inc., Hagerstown, MD), 
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hematocrit/hemoglobin and blood chemistries Prior to surgery, patients were encouraged 
to drink electrolyte-containing fluids ad libitum and have a light protein breakfast.  
In the first study, patients underwent larger volumes of infiltration by either WAL or 
traditional liposuction to their abdomens, back rolls, thighs, axillae and brachii to obtain 
data on 1) total infiltration/aspiration volumes, 2) total lidocaine dose (mg), total lidocaine 
dosage (mg/kg), and 3) hemodynamic stability and urine output. WAL uses a two-
chambered cannula that can independently either channel pulsations of tumescent solution 
(to loosen the fat and provide anesthesia) or spray pulses of tumescent fluid and 
simultaneously suction the rinsed, mobilized fatty tissue. Each WAL patient was treated in 
the three sequential stages. In Phase 1, pulses of tumescent solution [0.05% lidocaine (50ml 
of 1% lidocaine), 1:1,000,000 epinephrine (1ml of 1:1000 epinephrine), and 20ml 8.4% sodium 
bicarbonate per liter of 0.9% normal saline] were infused at the lowest rate of 90 ml/minute 
to provide localized anesthesia, vasoconstriction and tissue rinsing in a non-turgid manner 
to the planned site(s). During Phase 2, simultaneous suctioning (750mm Hg) and continuous 
pulsed infiltration, using a tumescent solution containing a reduced 0.025% lidocaine dose, 
evacuates the fatty tissue and a significant portion of the infusate. In Phase 3, a finishing 
cannula removes remnants of fatty tissue beneath the dermis with concurrent suctioning 
and lower rates of pulsed infiltration with 0.025% lidocaine solution. On the other hand, 
traditional liposuction patients were treated by superwet technique with the same 
tumescent solution, used in Phase 1 of WAL, prior to liposuction. Volumes (ml) and ratios of 
infiltration/aspiration/fat, lipocrits and urine output were calculated during and after 
surgery in the recovery room with each type of liposuction method.  
In the second IRB study, two patients participated in the investigation of plasma and 
subcutaneous fluid lidocaine concentration levels, obtained over twenty-four hours during 
and after WAL abdominal liposuction, to determine the time and magnitude of peak values. 
In addition, total infiltration/aspiration volumes, total lidocaine dosage (mg), total lidocaine 
dosage (mg/kg), and urine output were recorded. Lidocaine concentration levels of plasma 
and fluid within the subcutaneous space were measured by the Emit 2000 Lidocaine Assay 
(Dade Behring, Inc., Cupertino, CA), a homogeneous enzyme immunoassay technique, 
based on competition between drug in the sample and drug labeled with recombinant 
glucose-6-phosphate dehydrogenase for antibody binding sites. Active enzyme converts 
oxidized nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance 
change measured by spectrophotometric analysis.  
In the third study (IRB, controlled, randomized), three patients received randomly assigned 
treatments of three cumulative phases of a WAL procedure within 4 x 10cm rectangles on 
their abdomens, with an additional control panel, listed in Table 1. Standardized 
photography, weight, body fat analyses, waist and hip circumferences were obtained at 
baseline and three months after treatment. Tissue reduction was assessed by using the 
Vectra 3D Software System (Canfield Scientific, Fairfield, NJ), that identified the permanent 
India ink markers around corners of each targeted site and calculated changes in horizontal, 
diagonal and perimeter baseline measurements compared to findings at three months. At 
the completion of the study, total abdominal liposuction was performed on each subject to 
achieve a final aesthetic result.  
Results 
Study 1. As shown in Table 2, twelve WAL patients (8 females; 4 males) with an ASA I 
classification underwent large infiltration volume and fat aspiration. Participants averaged a 
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mean age of 49.0 years (range 29-61 years), mean weight of 71.1kg (range 51.7-98.9 kg), mean 
height of 1.7 meters (range 1.3-1.9 meters), mean body mass index of 25.2 (range 21.0 -30.2), 
and mean body fat of 31.9% (range 23.0-35.0%). As summarized in Table 3, thirteen TL 
patients (10 females; 3 males) with an ASA I classification underwent large infiltration 
volume and fat aspiration. This group of patients averaged a mean age of 53.3 years (range 
32-63 years), mean weight of 77.5kg (range 67.1-94.3kg), mean height of 1.7 meters (range 
1.5-1.9 meters), mean body mass index of 27.4 (range 24.0-30.3), and mean body fat of 33.7% 
(range 27.8-36.4%).  
 
Panel Treatment Assignment 
1 Control 
2 Phase 1: Infiltration Solution (25ml)  
 (25 cannula passes) 
3 Phase 1: Infiltration Solution (25ml)  
 (25 cannula passes) 
Phase 2: Simultaneous Suctioning (100ml) and Infiltration (225ml)  
 (25 cannula passes) 
4 Phase 1: 25ml Infiltration Solution (25 cannula passes)  
Phase 2: Simultaneous Suctioning (100ml) and Infiltration (225ml)  
 (25 cannula passes) 
Phase 3: Simultaneous Suctioning (25ml) and Infiltration (50ml)  
 (10 cannula passes) 
Table 1. Target Zones and Treatments 
WAL patients received almost all their total fluid support from infiltration solutions which 
served as their anesthetic solution, maintenance fluid, and volume replacement fluid (Table 
2). The average total subcutaneous infiltration volume was measured at 6239ml (range 4920-
7500ml), while the average aspiration volume was calculated at 5460ml (range 4350-6900ml). 
The average infiltration-to-aspiration ratio was 1.2:1 (range 1.1:1-1.3:1). The average volume 
of aspirated fat was 2456ml (range 1716-3105ml), which calculated to an average infiltration-
to-fat ratio of 2.6:1 (range 2.2:1-3.0:1) and an average fat-to-aspirate percentage of 44.9% 
(range 37.6-56.2%). During surgery, patients received an average total lidocaine dose of 
1702mgs (range 1423-2095mgs) and an average lidocaine dosage of 24.2mg/kg (range 18.9-
33.6mg/kg)  
In contrast, TL patients received their total fluid support both from the infiltration 
tumescent solution and intravenous saline fluid resuscitation (Table 3). The average total 
subcutaneous infiltration volume was measured as 5350ml (range 4500-6500ml), while the 
average aspiration volume was calculated at 5042ml (range 4000-6000ml). The average 
infiltration-to-aspiration ratio was 1.1:1 (range 1.0:1-1.1:1). The average volume of aspirated 
fat was 4036ml (range 3280-4800ml), which calculated to an average infiltration-to-fat ratio 
of 1.3:1 (range 1.2-1.6) and an average fat-to-aspirate percentage of 80.2% (range 70.0-86.0%). 
During surgery, patients received an average total lidocaine dose of 2675mg (range 2450-
3100mg) and an average lidocaine dosage of 34.8mg/kg (range 27.0-40.9mg/kg).  
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Pt # Age 
Wt 
(kg) 
Ht
(m)
BMI
Total
Lido
(mg)
Lido 
Dosage
(mg/kg)
Total 
Infiltratio
n (ml) 
Total 
Aspiratio
n(ml) 
I/A 
Ratio*
Total 
Fat
(ml)
I/F 
Ratio** 
F/A 
(%) 
1 29 97.5 1.8 30.2 1690 17.3 5760 4900 1.2:1 2500 2.3:1 51.0 
2 44 51.7 1.7 23.0 1735 33.6 5940 4700 1.3:1 2021 2.9:1 43.0 
3 61 54.0 1.5 21.8 1480 27.4 4920 4400 1.1:1 1716 2.9:1 39.0 
4 57 56.2 1.3 23.4 1550 27.6 5200 4812 1.1:1 2117 2.4:1 44.0 
5 42 92.5 1.7 28.0 2095 22.6 7375 6900 1.1:1 3105 2.4:1 45.0 
6 60 98.9 1.9 28.0 1600 16.2 5400 4350 1.2:1 1783 3.0:1 41.0 
7 55 70.3 1.7 23.5 1767 25.1 7000 6885 1.0:1 2592 2.7:1 37.6 
8 45 67.0 1.6 27.1 1833 27.5 7500 6550 1.1:1 3050 2.4:1 46.5 
9 44 63.5 1.6 25.8 1684 26.5 6550 5575 1.2:1 2174 3.0:1 39.0 
10 46 52.0 1.6 21.0 1423 18.9 6050 5550 1.1:1 2775 2.2:1 50.0 
11 56 82.5 1.8 27.0 1767 21.4 6600 5375 1.2:1 3020 2.2:1 56.2 
12 49 66.8 1.7 23.3 1800 26.9 6575 5525 1.2:1 2630 2.5:1 47.6 
Avg. 49 71.1 1.7 25.2 1702 24.2 6239 5460 1.2:1 2456 2.6:1 44.9 
* Infiltration-to-Aspiration Ratio ** Infiltration-to-Fat-Ratio 
Table 2. Demographic and Clinical Data in Twelve Patients for Larger Volume Water-
Assisted Liposuction 
 
Pt # Age 
Wt 
(kg) 
Ht 
(m)
BMI
Total 
Lido 
(mg) 
Lido 
Dosage 
(mg/kg)
Total 
Infiltration 
(ml) 
Total 
Aspiration
(ml) 
I/A 
Ratio*
Total 
Fat 
(ml) 
I/F 
Ratio** 
 
F/A 
(%) 
1 61 74.8 1.7 26.0 2750 36.8 5500 5200 1.1:1 4108 1.3:1 79.0 
2 53 73.4 1.5 26.0 3000 40.8 6000 5500 1.1:1 3850 1.6:1 70.0 
3 37 81.6 1.7 28.2 2625 32.4 5250 5000 1.1:1 4050 1.3:1 81.0 
4 68 92.9 1.9 26.5 2600 27.9 5200 4990 1.0:1 4142 1.2:1 83.0 
5 63 79.3 1.6 28.0 3250 40.9 6500 6000 1.1:1 4740 1.4:1 79.0 
6 62 78.4 1.6 29.2 3100 39.5 6200 6000 1.0:1 4800 1.3:1 80.0 
7 49 72.5 1.6 25.2 2500 34.4 5000 4950 1.0:1 3811 1.3:1 76.9 
8 32 74.8 1.6 30.3 2250 30.1 4500 4000 1.1:1 3280 1.4:1 82.0 
9 53 67.1 1.5 28.0 2650 39.5 5300 5000 1.1:1 4150 1.3:1 83.0 
10 62 94.3 1.8 29.0 2550 27.0 5100 5000 1.0:1 3900 1.3:1 78.0 
11 49 74.8 1.7 26.0 2500 33.4 5000 4900 1.0:1 4214 1.2:1 86.0 
12 49 70.4 1.5 29.0 2450 35.1 4900 4500 1.1:1 3645 1.3:1 81.0 
13 55 72.7 1.6 24.0 2550 34.8 5100 4500 1.1:1 3780 1.3:1 84.0 
Avg 53.3 77.5 1.7 27.4 2675 34.8 5350 5042 1.1:1 4036 1.3:1 80.2 
*Infiltration-to-Aspiration Ratio **Infiltration-to-Fat Ratio 
Table 3. Demographic and Clinical Data in Thirteen Patients for Larger Volume Traditional 
Liposuction  
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The average operating time for the larger volume WAL group was 4.0 hours (range 3.0-5.0 
hours), while the average time in the recovery room was 1.4 hours (Table 4). The average 
tumescent infiltration fluid rate was 24.8ml/kg/hr (range 13.1-38.8 ml/kg/hr). The average 
urine output in surgery was 1.8 ml/kg/hr (range 1.3-2.5 ml/kg/hr), while the average urine 
output in the recovery room was 2.2ml/kg/hr (range 1.5-2.7ml/kg/hr). As cited in Table 5, 
similar data was obtained from the larger volume TL patients who demonstrated an average 
operating time of 3.5 hours (range 3.0-4.0 hours) and an average recovery time of 1.3 hours 
(range 1.0-1.5 hours). The average tumescent infiltration fluid rate during surgery was 
20.4ml/kg/hr (range 15.5-27.0ml/kg/hr). The average urine output in surgery was 
2.0ml/kg/hr (range 1.3-2.7ml/kg/hr), while the average urine output in the recovery room 
was 2.1mlkg/hr (range 1.7-2.4ml/kg/hr). The majority of patients were monitored for over 12 
hours after surgery.  
 
Pt # OR 
Time 
(hrs) 
Recovery 
Time OR
(hrs) 
Infiltration Fluid         Urine Output Rate
Rate (ml/kg/hr)                 (ml/kg/hr) 
During Surgery               During Surgery
Recovery Room Urine 
Output 
(ml/kg/hr) 
1 4.5 1.5 13.1                                  1.3 1.2 
2 3.0 1.5 18.4                                   1.8 1.7 
3 3.0 1.25 16.8                                    1.7 1.5 
4 4.0 1.5 11.9                                    1.3 1.2 
5 3.0 1.5 11.7                                    2.0 1.2 
6 3.5 1.5 15.2                                    1.3 1.3 
7 5.0 1.5 19.9                                    2.1 2.5 
8 4.0 1.0 28.0                                    1.7 2.0 
9 3.5 1.2 29.5                                    1.5 2.2 
10 3.0 1.5 38.8                                    1.8 2.3 
11 5.0 1.5 16.0                                    2.5 2.7 
12 5.0 1.0 19.7                                    2.2 2.4 
Avg. 4.0 1.4 24.8                                    1.8 2.2 
Table 4. Operating/Recovery Times, Infiltration Fluid Rates and Urine Output Rates in 
Larger Volume Water-Assisted Liposuction 
In both WAL and TL groups, lipocrits of less than 1.0% were estimated from millimeters of 
red blood cell presence and millimeters of non-red blood cell containing fluid from aspirates 
measured within centrifuged capillary tubes from final aspirates in each patient. 
Preoperative hematocrit, hemoglobin, electrolytes, blood urea nitrogen/creatinine and liver 
function test levels demonstrated no significant changes from their 3-month postoperative 
values. During surgery and the perioperative period, episodes of tachycardia, hypotension, 
excessive bleeding, dyspnea/wheezing, significant detectable fluid shifts, pulmonary 
edema, congestive heart failure, or low urine output were not observed. Each patient was 
assessed to be stable hemodynamically throughout the entire procedure and in the recovery 
period. 
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None of the TL or WAL patients developed in the immediate postoperative period or after 
6-month follow-ups infections, deep venous thrombosis or skin loss. Subjective assessments 
of postoperative pain suggest that WAL patients on an individual basis experienced less 
pain and discomfort and were able to resume normal pre-surgical activities more rapidly 
than TL patients. There were no significant differences in the low incidences of ecchymoses, 
surface irregularities and nodular fibroses between the two treatment groups.  
 
Pt. # OR 
Time 
(Hrs) 
Recovery 
Time OR
(Hrs) 
Parenteral and Infiltration     Fluid Urine Output 
Rate (ml/kg/hr)                          Rate (ml/kg/hr) 
During Surgery                              During Surgery 
Recovery Room 
Output 
(ml/kg/hr) 
1 3.5 1.5 20.9                                              2.3 2.2 
2 3.0 1.5 27.0                                              2.0 2.4 
3 3.0 1.0 21.3                                              2.5 2.1 
4 2.5 1.5 22.4                                              2.6 2.3 
5 4.0 1.0 20.6                                              2.7 2.0 
6 3.5 1.0 22.0                                              1.9 2.0 
7 4.0 1.0 17.2                                              1.5 1.7 
8 4.0 1.5 15.0                                              1.3 1.5 
9 4.0 1.5 19.8                                              2.1 2.4 
10 3.5 1.0 15.5                                              2.0 2.2 
11 3.0 1.0 22.3                                              1.7 1.9 
12 3.0 1.5 23.2                                              1.5 2.0 
13 4.0 1.5 17.5                                              1.9 2.2 
Avg 3.5 1.3 20.4                                              2.0 2.1 
Table 5. Operating/Recovery Time, Infiltration Fluid, Rates and Urine Output Rates in 
Larger Volume Traditional Liposuction 
Study 2. Two female subjects with an ASA I classification volunteered for lidocaine levels in 
plasma and fluid within the subcutaneous space during and after liposuction of their 
abdomens. The following demographic measurements from subject 1 and subject 2 were 
obtained, respectfully: age (33yr, 47yr), height (1.7m, 1.6m), weight (78.6Kg, 59.0Kg), body 
fat (38.3%, 36.0%), and BMI (27.2, 23.9). For each respective subject, the total tumescent 
infiltration volumes (5900ml, 3050ml), final aspiration volumes (5500ml= 750ml fat + 4750ml 
infranate); 3050ml = 575ml fat + 1875ml infranate), total lidocaine doses (1700mg, 975mg), 
and lidocaine dosages (29.5mg/kg, 12.5mg/kg2) were tabulated. In subject 1, the average 
tumescent infiltration fluid rate was 25.0ml/kg/hr, while the average urine output during 
surgery and in the recovery room was 1.5ml/kg/hr. In subject 2, the average tumescent 
infiltration fluid rate was 17.2ml/kg/hr, while the total urine output was 2.1ml/kg/hr. 
Serial lipocrits were calculated less than 1.0% of infranates collected from each subject. 
Preoperative blood work demonstrated no significant changes from 3 month post-operative 
values. During surgery and postoperative recovery period (average 3 hours), subjects did 
not exhibit any deleterious signs or symptoms that could be attributed to lidocaine toxicity 
or fluid overload. Patients received no parenteral fluid support other than tumescent 
infiltration and were observed to be hemodynamically stable throughout the office 
procedure and continued recovery at home. 
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Lidocaine concentrations in plasma and fluids with the subcutaneous space were measured 
by enzyme immunoassay technique and plotted by connecting the sequential levels for a 
continuous curve over 24 hours (Figure 1). The peak occurrence of the peak plasma 
lidocaine concentration, were observed at about 9 hours in both subjects. At 30 minutes, 
elevated plasma levels were measured at 0.5-0.1µg/ml, gradually rising to peak levels 
between 0.80-0.95µg/ml, and falling to 0.30µg/ml at 24 hours. All recorded plasma levels 
were lower than elevated levels from subcutaneous fluids within the tumescent-treated 
abdomens measured between 1-1 ½ hours (95-130ug/ml) and after 6-8 hours (66-95µg/ml) 
from the start of lidocaine infiltration. 
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Fig. 1. Serial lidocaine levels in plasma and fluid within subcutaneous space during and 
after WAL procedures. 
Study 3. Three female patients with ASA I classifications had an average age of 46 years 
(range 26-66 years). Each patient’s pretreatment weight, percent body fat, BMI, and hip 
circumference did not vary significantly from the measurements 3 months after surgery. In 
each subject, a reduction in waist circumference from baseline to 3 months was observed 
(Table 6). 
Results of surface area changes from baseline to 3 months within the four isolated 
rectangles, as determined by Vectra 3D analysis, are shown in Figure 2. Each target panel 
received cumulative components of the standard treatment protocol for a WAL procedure. 
At the three month evaluation period, the difference in mean percent area of tissue 
reduction between panel 1 (control) and panel 2 (subcutaneous infiltration) was negligible. 
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However, the increases in mean percent area of tissue reduction, observed in panel 3 (6.8%) 
and in panel 4 (6.7%) over control (0.0%) and panel 1 (1.2%), indicate that the removal of fat 
facilitates increased the accommodation, retraction or contraction of the overlying skin.  
 
Pt 
# 
Weight (kg) % Body Fat Body Mass 
Index 
Waist 
Circum.(cm) 
Hip Circum. 
(cm) 
 0 
mos 
3  
mos 
0 
mos 
3 
mos 
0 
mos 
3 
mos 
0 
mos 
3  
mos 
0  
mos 
3 
mos 
1 67.3 68.6 40.8 42.6 26.2 26.8 94.5 92.0 106.0 106.0 
2 79.5 79.1 38.1 37.5 25.9 25.8 109.5 105.0 108.0 107.5 
3 83.6 83.2 39.6 40.5 30.7 30.5 105.0 101.0 107.0 106.0 
Table 6. Patient Demographics in Abdominal Tissue Tightening Study 
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Fig. 2. Average 3-Dimensional Abdominal Surface Area Reduction in 3 Patients by 
Treatment Phases of WAL by Canfield Vector 3D Analyses at 3 Months. 
3. Discussion 
Traditional liposuction continues to be the gold standard to remove fat and contour body 
shapes. Since 1986, advocates preferred either a superwet9,15-17,28-31 or a tumescent technique2-
8,10,, each of which have established proven safety and efficacy profiles using similar 
anesthetic solutions, but with significantly differing ratios of infiltration volume to total 
aspiration volumes. Each technique appears to be safe when strict clinical criteria11-14 are 
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observed such as selecting ASA I patients, using less than 5 liters of dilute volumes of 
lidocaine and epinephrine for average cases, limiting total lipoaspirates to less than 5 liters 
in the outpatient setting, respecting the safe maximum 35mg/kg of lidocaine, and 
prolonging patient discharge for large volume cases because of various factors delaying 
peak lidocaine levels as late as 10 to 15 hours. In particular, safer outcomes have been 
reported when the physiologic impact of larger volume liposuction is understood in cases 
that are associated with significant fluid shifts, third space losses, and potential epinephrine 
and lidocaine side-effects and toxicities. 
In larger cases, superwet technique28-31 is usually associated with the use of parenteral fluid 
maintenance and replacement with total intravenous or general anesthesia, while Klein’s 
tumescent technique6-7, 10 recommends the elimination for parenteral fluid support or total 
intravenous/general anesthesia in large volume cases. With either technique, however, the 
issue of absorption of the tumescent fluid infiltrate is complicated by the removal of the 
infiltrate along with fat and blood during suctioning. Since most of the infiltrate, ranging 
from 22-29 percent, is not removed by suctioning, at least 70 percent of the infiltrate is 
believed to remain after the procedure20, 49. Fluid overload28, 33, 41, 51-53 becomes possible 
whenever substantial amounts of tumescent infiltrative fluids or parenteral fluids are used 
in high volume cases with the tumescent (3-4:1 ratio) and superwet (1- 1.5:1) techniques. 
Since WAL’s variable force infusion pump pulses fan-shaped jets of tumescent solution into 
the subcutaneous fatty tissue during its three procedural phases, but only suctions 
simultaneously the loosened fat and fluid during the latter two phases, the final 
physiological and pharmacological impact is expected to reflect more closely the infiltration-
to-aspiration ratios (between 3-4:1) observed with the tumescent technique. The author’s 
recent WAL publication39 provided, however, evidence to the contrary by recording an 
average 1.1:1 infiltration to aspiration ratio in fifty small-moderate infiltration volume cases.  
 Although the present study 1 data was underpowered for statistical significance, the 
observed results indicated that WAL and TL exhibited a comparative safety margin in 
similar types of cases for larger volumes of infiltrated tumescent solution, lipoaspiration, 
and fat removal, respectfully: average total infiltration (WAL, 6239ml; TL, 5350ml); total 
aspiration (WAL, 5460ml; TL, 5042ml, and total fat (WAL, 2456ml; TL, 4036ml). In these 
cases, the average calculated infiltration-to-aspiration ratios were similar (WAL, 1.2:1; TL, 
1.1:1), approaching that observed in typical cases using superwet technique (1-1.5:1) rather 
than that experienced with the Klein tumescent technique (3-4:1). Although explanations for 
WAL’s findings as a superwet technique are unclear, the data suggest that simultaneous 
infiltration- aspiration for the greater part of the procedure in phases 2 and 3 may account 
for the observed balanced I/A ratio, as found with TL procedures. In this study, the use of 
WAL, however, resulted in a  
lower average fat-to-aspiration ratio (44.9%) than that observed with TL (80.2%) or with 
other devices17, 19-21, 42, 46, 54 that commonly experience 70-90% fat-to-aspiration ratios in 
comparable volume cases. These findings suggest that WAL may be more inefficient in 
removing more fibrous fat from the back rolls and upper abdomen than TL.  
In this study, the average total lidocaine dose was larger in TL patients (2675mg) than in 
WAL patients(1702mg) because of higher concentrations delivered during the entire 
procedure in TL patients (0.05% lidocaine, average 5350ml total tumescent infiltration) than 
in WAL patients ( phase 1, 0.05%; phases 2-3, 0.025% lidocaine, average 6239ml total 
tumescent infiltration). For similar reasons, the lidocaine dosage exposure was greater in the 
TL patients (34.8mg/kg) than in WAL patients (24.2mg/kg).  
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Although the average tumescent fluid infiltration volume (24.8ml/kg/hr) in the WAL 
patients provided the only fluid replacement, urine output safely averaged about 1.8 
ml/kg/hr during surgery and 2.2ml/kg/hr in the postoperative recovery period. In the TL 
patients, the average tumescent fluid infiltration volume (5350ml) was augmented by 
parenteral intravenous fluid support (average 1000ml ringer’s lactate) for a total infiltration 
fluid rate of 20.4ml/kg/hr during surgery to maintain an average urine output rate of 
2.0ml/kg/hr in surgery and 2.1ml/kg/hr in the recovery room. In both procedures, clinical 
parameters of fluid overload (pulmonary edema, dyspnea, wheezing, congestive heart 
failure), low maintenance fluid replacement (tachycardia, hypotension, low urine output), 
and significant blood loss attributable to the procedure were not observed. In larger 
infiltration volume WAL or TL cases, however, patients must be provided with an available 
intravenous access site, be the recipient of prewarmed tumescent fluids, supported by a 
warming blanket and an anti-embolic calf/ankle pumps, and monitored fluid outputs with 
a urinary catheter. The information from this limited comparison of techniques does not 
significantly add to previously published data4, 6,10,15,50, but confirms the safety profile 
during larger infiltration and liposuction cases under local anesthesia. Along with sound 
clinical judgment, both techniques may be performed safely under strict preoperative 
criteria, intraoperative fluid monitoring, and postoperative assessments for at least 12 hours. 
Overnight stays are recommended for monitoring of vital signs and fluid resuscitation in 
larger volume cases. 
The pharmacokinetics of dilute amounts of lidocaine4, 6, 21, approaching 35mg/kg, and 
epinephrine into subcutaneous fat with relatively large volumes of fluid have been found to 
be safe with the tumescent technique because of slow absorption of lidocaine in the presence 
of epinephrine, poor vascularity of fatty tissue, and the removal of a variable amount of 
much of the infused lidocaine by suction before systemic absorption. In studies21-27, 55 
associated with high dosages, peak serum levels below toxic levels of 5µg/ml were 
measured about 10-12 hours after infiltration. In the second part of this study, the lidocaine 
dosages used in the two patients were calculated at 12.5mg/kg and 29.5mg/kg, exceeding 
the recommended the safe limit of lidocaine dosage of 7mg/kg with epinephrine in normal 
healthy adults31,40, but below the estimated maximal safe dosage of 35mg/kg, as 
recommended in the Klein tumescent technique12. The low plasma peak levels between 0.80-
0.95µg/ml at 9 hours and the elevated subcutaneous fluid levels from lipoaspirates at 1-1 ½ 
hours (95-130µg/ml) and after 6-8 hours (66-95µg/ml) from the start of lidocaine infiltration 
were consistent and similar with those observed in previous cited publications. These 
results confirm the relative safeness of using larger infiltration volumes with simultaneous 
liposuction during the WAL technique. Because of costs, the study was limited to few 
patients and used an enzyme immunoassay technique that was unable to measure the 
variability in protein binding and active metabolites of lidocaine (monoethylglycinexylide 
and glycinexylidide)32, which can be over 80% active and contribute to lidocaine toxicity. 
Although no significant side effects have been reported with higher lidocaine dosages33, 55, 
further expanded clinical and laboratory studies need to be performed to determine the 
optimal lidocaine dose for WAL to provide complete local anesthesia.  
Although the number of patients in third part of the study is small for statistical 
significance, the observed results indicated tissue accommodation after WAL treatments. In 
younger patients who present with minimal laxity to the overlying skin, the removal of fat 
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can be expected to result in normal skin retraction, as observed in panels 3 and 4. There 
exists no evidence from this study that this beneficial finding was due to the preservation of 
the septal architecture. In the future, one of the challenges for WAL, as with other energized 
liposuction devices42-47, is to investigate the contribution of energy in the form of mechanical 
or thermal injury to improve tissue reduction/contraction in the skin-challenged patient. 
Their limited clinical benefit brings into perspective the cost-benefit value of thermally-
equipped devices for tissue tightening and emphasizes the need for further clinical research 
and applications48. 
In conclusion, we believe that larger-volume liposuction is safe and efficacious by WAL 
compared to TL, provided attention is directed to tumescent anesthesia, fluid replacement 
and overload, blood loss and postoperative monitoring for potential lidocaine side-effects. 
4. Conclusions 
On the basis of our limited and preliminary study, patients undergoing WAL procedures, as 
well as TL procedures, are safe for cases involving larger infiltration/aspiration volumes 
that introduce the possibility of lidocaine side-effects and toxicities and fluid imbalance. 
Patients did not experience significant adverse events in this study. Specifically, this brief 
study demonstrated that current algorithm with WAL treatments results in peak plasma 
lidocaine levels between 0.80-0.95ug/ml around 9 hours when subcutaneous fluid levels 
were elevated around 95-130ug/ml at 1-1½ into surgery and 66-95µg/ml at 6-8 hour after 
lidocaine infiltration. Although the correlation between total plasma lidocaine concentration 
(<5µg/ml) and the predictability of specific toxicity is tenuous at best and can lead to false 
sense of security, the surgeon must always be mindful of careful clinical monitoring during 
and at least 24 hours after completion of the procedure. In addition, preliminary results, 
indicating a small but positive trend for skin reduction by Vectra 3D analysis, remain 
underpowered for significance and will require larger number of patients for statistical 
validation.  
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